• Eran Beit Ner, Guy Ron, Ahmad Essa, Almog Levy, Aharon S Finestone, and Eran Tamir.
• Department of Orthopedic Surgery, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel.
• Isr Med Assoc J. 2022 Jul 1; 24 (7): 470474470-474.

BackgroundLower extremity amputation related to diabetes is a serious outcome, which can have devastating effects on the patient and family. The epidemiology of amputations has recently been used as a possible measure of the adequacy of medical prevention and treatment of diabetes and diabetic foot complications.ObjectivesTo report on patients undergoing amputations at one medical center in Israel, their co-morbidities, and the outcomes.MethodsA retrospective chart study was conducted of amputees operated between 1 September 2017 and 30 September 2018.ResultsThe study population comprised 72 patients who had major amputations for diabetes and/or ischemia, mean age 72 ± 10 years, 74% males, 93% with type 2 diabetes. Mean age corrected Charlson Comorbidity Index was 8.2 ± 2.1 with 90% (65 patients) presenting with a score of 6 or higher. Before the recent deterioration, fewer than 20% of the patients exited their home routinely and 24% had an official diagnosis of dementia. There were 31 below knee amputations (BKA) and 41 above knee amputations (AKA). The 30-day, 3-month, 1-year, and 2-year mortality rates were 15.3%, 27.8%, 43.1%, and 54.2% respectively. Median survival period was 20 months. Survival after AKA was 13.4 ± 20, which was significantly less than after BKA (25.4 ± 2.7, P = 0.097).ConclusionsFactors other than the quality of management of patients with diabetes and complications may contribute to amputation rates; thus, making speculations from international comparisons of raw amputation rates problematic. This population was less healthy than reported in most studies.

20 keywords...

hide…